CY2584B2 - Pharmaceutical granules - Google Patents

Pharmaceutical granules

Info

Publication number
CY2584B2
CY2584B2 CY0500056A CY0500056A CY2584B2 CY 2584 B2 CY2584 B2 CY 2584B2 CY 0500056 A CY0500056 A CY 0500056A CY 0500056 A CY0500056 A CY 0500056A CY 2584 B2 CY2584 B2 CY 2584B2
Authority
CY
Cyprus
Prior art keywords
pharmaceutical granules
granules
pharmaceutical
Prior art date
Application number
CY0500056A
Other languages
English (en)
Inventor
Hidero Akiyama
Zene Matsumoto
Takashi Ueno
Original Assignee
Novartis Int Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Int Pharm Ltd filed Critical Novartis Int Pharm Ltd
Publication of CY2584B2 publication Critical patent/CY2584B2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CY0500056A 1995-09-09 2005-10-18 Pharmaceutical granules CY2584B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518465.1A GB9518465D0 (en) 1995-09-09 1995-09-09 Pharmaceuticals
PCT/JP1996/002504 WO1997010810A2 (en) 1995-09-09 1996-09-04 Pharmaceutical granules

Publications (1)

Publication Number Publication Date
CY2584B2 true CY2584B2 (en) 2009-11-04

Family

ID=10780470

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0500056A CY2584B2 (en) 1995-09-09 2005-10-18 Pharmaceutical granules

Country Status (15)

Country Link
US (3) US6242008B1 (pt)
EP (1) EP0850048B1 (pt)
JP (1) JP2000504309A (pt)
AR (1) AR004196A1 (pt)
AT (1) ATE269695T1 (pt)
AU (1) AU6889396A (pt)
CO (1) CO4750645A1 (pt)
CY (1) CY2584B2 (pt)
DE (1) DE69632787T2 (pt)
ES (1) ES2224175T3 (pt)
GB (1) GB9518465D0 (pt)
PT (1) PT850048E (pt)
TW (1) TW426525B (pt)
WO (1) WO1997010810A2 (pt)
ZA (1) ZA967545B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000128774A (ja) * 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
MXPA02004650A (es) * 1999-11-12 2002-09-02 Scherer Technologies Inc R P Granulos amortiguadores de celulosa microcristalina.
GB0010446D0 (en) * 2000-04-28 2000-06-14 Glaxo Wellcome Kk Pharmaceutical formulation
US6958908B2 (en) * 2003-05-30 2005-10-25 Hubbell Incorporated Compact enclosure for interchangeable SONET multiplexer cards and methods for using same
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
EP2654089A3 (en) 2007-02-16 2015-08-12 Nanogram Corporation Solar cell structures, photovoltaic modules and corresponding processes
WO2010001574A1 (ja) 2008-07-01 2010-01-07 沢井製薬株式会社 タムスロシン塩酸塩を含有する球形微粒子の製造方法
AU2010356101B2 (en) * 2010-06-23 2013-08-29 Colgate-Palmolive Company Encapsulation of ingredients in lactose matrix to form active encapsulates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713245A (en) * 1984-06-04 1987-12-15 Mitsui Toatsu Chemicals, Incorporated Granule containing physiologically-active substance, method for preparing same and use thereof
CA1331713C (en) * 1988-12-29 1994-08-30 Hitoshi Iijima Granular composition for ruminant
DK0472502T3 (da) 1990-08-24 1995-10-09 Spirig Ag Fremgangsmåde til fremstilling af pellets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
JP3316243B2 (ja) * 1993-01-18 2002-08-19 川鉄鉱業株式会社 粉末シリカの高分散性造粒物及びその製造方法
IT1264020B (it) 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
GB9413724D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
AU6889396A (en) 1997-04-09
DE69632787D1 (de) 2004-07-29
ES2224175T3 (es) 2005-03-01
AR004196A1 (es) 1998-11-04
ATE269695T1 (de) 2004-07-15
DE69632787T2 (de) 2005-08-18
GB9518465D0 (en) 1995-11-08
US20030072809A1 (en) 2003-04-17
EP0850048A2 (en) 1998-07-01
WO1997010810A3 (en) 1997-06-05
ZA967545B (en) 1998-05-12
WO1997010810A2 (en) 1997-03-27
PT850048E (pt) 2004-09-30
JP2000504309A (ja) 2000-04-11
US6242008B1 (en) 2001-06-05
EP0850048B1 (en) 2004-06-23
TW426525B (en) 2001-03-21
CO4750645A1 (es) 1999-03-31
US6410055B1 (en) 2002-06-25

Similar Documents

Publication Publication Date Title
IL116913A0 (en) Novel pharmaceutical combination
ZA96448B (en) Tablet
EP0850057A4 (en) PHARMACEUTICAL COMPOSITIONS
CY2584B2 (en) Pharmaceutical granules
AU128017S (en) Pharmaceutical tablet
AU129056S (en) Pharmaceutical tablet
GB9525963D0 (en) Pharmaceutical compounds
SI0850048T1 (en) Pharmaceutical granules
GB9521970D0 (en) Novel pharmaceutical
GB9521918D0 (en) Novel pharmaceutical
CA77348S (en) Tablet
GB9507678D0 (en) Pharmaceutical mixtures
GB9526437D0 (en) Pharmaceutical compounds
GB9522132D0 (en) Pharmaceutical compounds
GB9517867D0 (en) Pharmaceutical compounds
GB9517866D0 (en) Pharmaceutical compounds
GB9517865D0 (en) Pharmaceutical compounds
GB9511166D0 (en) Pharmaceutical compounds
GB9506273D0 (en) Pharmaceutical compounds
GB9502811D0 (en) Pharmaceutical compounds
GB9502542D0 (en) Novel pharmaceutical use
PL307197A1 (en) Pharmaceutical agent
GB9522579D0 (en) Pharmaceuticals
GB9517308D0 (en) Pharmaceuticals
GB9508237D0 (en) Pharmaceuticals